Cargando…
Effects of Evolocumab on Carotid Intima-Media Thickness and Clinical Parameters in Patients Taking a Statin
We determined the effects of evolocumab, a fully human monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9, on carotid intima-media thickness (IMT) and the factors associated with the change in carotid IMT in patients taking a statin. The change in carotid mean and maximum IM...
Autores principales: | Hirai, Keiji, Imamura, Shigeki, Hirai, Aizan, Ookawara, Susumu, Morishita, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408755/ https://www.ncbi.nlm.nih.gov/pubmed/32708615 http://dx.doi.org/10.3390/jcm9072256 |
Ejemplares similares
-
Risk factors and utility of maximum carotid intima–media thickness as a surrogate marker for coronary artery stenosis
por: Hirai, Keiji, et al.
Publicado: (2018) -
Effect of Evolocumab on Vulnerable Coronary Plaques: A Serial Coronary Computed Tomography Angiography Study
por: Hirai, Keiji, et al.
Publicado: (2020) -
Factors Associated with the Change in Carotid Maximum Intima-Media Thickness in Patients with Moderate-to-Advanced Stage Chronic Kidney Disease
por: Hirai, Keiji, et al.
Publicado: (2020) -
Sarcopenia and Physical Inactivity in Patients With Chronic Kidney Disease
por: Hirai, Keiji, et al.
Publicado: (2016) -
Changes in cerebral oxygenation during hemodialysis before and after carotid artery stenting
por: Sato, Hisashi, et al.
Publicado: (2022)